KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fedex (FDX) Asset Writedowns and Impairment (2016 - 2026)

Fedex's Asset Writedowns and Impairment history spans 17 years, with the latest figure at $250.0 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment rose 106.61% year-over-year to $250.0 million; the TTM value through Nov 2025 reached $240.0 million, down 47.14%, while the annual FY2025 figure was $21.0 million, 95.01% down from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 was $250.0 million at Fedex, up from $219.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $250.0 million in Q4 2025 and bottomed at -$419.0 million in Q2 2023.
  • The 5-year median for Asset Writedowns and Impairment is $116.5 million (2021), against an average of $85.8 million.
  • The largest annual shift saw Asset Writedowns and Impairment tumbled 651.32% in 2023 before it surged 123.39% in 2024.
  • A 5-year view of Asset Writedowns and Impairment shows it stood at $94.0 million in 2021, then surged by 91.49% to $180.0 million in 2022, then tumbled by 37.22% to $113.0 million in 2023, then increased by 7.08% to $121.0 million in 2024, then soared by 106.61% to $250.0 million in 2025.
  • Per Business Quant, the three most recent readings for FDX's Asset Writedowns and Impairment are $250.0 million (Q4 2025), $219.0 million (Q3 2025), and -$361.0 million (Q2 2025).